332 results on '"Chiron, David"'
Search Results
2. A uniqueness result for the two vortex travelling wave in the Nonlinear Schrodinger equation
3. A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics
4. Unraveling MCL biology to understand resistance and identify vulnerabilities
5. CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma
6. Coercivity for travelling waves in the Gross-Pitaevskii equation in $\mathbb{R}^2$ for small speed
7. Smooth branch of travelling waves for the Gross-Pitaevskii equation in $\mathbb{R}^2$ for small speed
8. Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53‐deficient myeloma cells.
9. Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
10. Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial
11. From Vlasov-Poisson and Vlasov-Poisson-Fokker-Planck Systems to Incompressible Euler Equations: the case with finite charge
12. Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma
13. Rarefaction pulses for the Nonlinear Schrodinger Equation in the transonic limit
14. Stability and instability for subsonic travelling waves of the Nonlinear Schr\'odinger Equation in dimension one
15. Traveling waves for nonlinear Schr\'odinger equations with nonzero conditions at infinity, II
16. A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals major role of BAX in BH3 mimetics response
17. A uniqueness result for the two-vortex traveling wave in the nonlinear Schrödinger equation
18. Smooth branch of rarefaction pulses for the Nonlinear Schrödinger Equation and the Euler–Korteweg system in 2d
19. p53 regulates CD46 expression and measles virus infection in myeloma cells
20. CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages
21. CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma
22. P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION.
23. Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma
24. The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition
25. Long wave asymptotics for the Euler--Korteweg system
26. Data from Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
27. Supplementary Table S3 from Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
28. Supplementary Figure S2 from Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
29. Supplementary Methods and Supplementary Figure Legends from Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
30. Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma
31. Pannexin‐1 limits the production of proinflammatory cytokines during necroptosis
32. Supplementary Figure 4 from Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
33. Data from Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
34. Supplementary Table 2 from Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
35. Supplementary Figure 1 from Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
36. Supplementary Figure 3 from Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
37. Supplementary Table 1 from Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
38. Supplementary Figure 2 from Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
39. Coercivity for travelling waves in the Gross-Pitaevskii equation in $\mathbb{R}^2$ for small speed
40. Coercivity for travelling waves in the Gross-Pitaevskii equation in R2 for small speed
41. Traveling Waves for Nonlinear Schrödinger Equations with Nonzero Conditions at Infinity
42. Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BH3-Mimetics in Experimental Models of Relapsed/Refractory Mantle Cell Lymphoma
43. CARD11 and BCL2A1 Join Forces to Promote Resistance to Ibrutinib/Venetoclax Combination in Lymphoma Patients
44. STP938, a Selective CTPS1 Inhibitor, Shows Single Agent Activity and Synergy with BCL2 Inhibition in Preclinical Models of Mantle Cell Lymphoma
45. TP53 CRISPR/Cas9 Reveals Strict BAX Dependence in the Response to BH3 Mimetic Targeting MCL1
46. Habilitation à Diriger les Recherches _ Habilitation à Diriger les Recherches
47. Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways
48. Travelling Waves for the Nonlinear Schrödinger Equation with General Nonlinearity in Dimension Two
49. BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma
50. Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.